Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer

40Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The prognostic value of lymph node ratio (LNR) in pancreatic cancer remains controversial. In the current retrospective study, we assessed the value of LNR on predicting the survival of postoperative patients with pancreatic cancer. Methods: Medical records of patients who underwent pancreatic resection for pancreatic cancer in the department of general surgery, Qilu Hospital, Shandong University were reviewed retrospectively. Demographic, clinicopathological, tumor-specific data, and histopathological reports were collected. Univariate and multivariate survival analyses were performed. Results: A total of 83 patients with pancreatic cancer were collected. The mean number of examined LN was 8.2 ± 6.1 (0 to 26). Differential degree (low) (P = 0.019, hazard ratio (HR) = 2.276, 95% confidence interval (CI): 1.171 to 4.424) and LNR > 0.2 (P = 0.018, HR = 2.685, 95% CI: 1.253 to 5.756) were independent adverse prognostic factors according to the multivariate survival analysis. Conclusions: Our study indicated that LNR > 0.2 was an independent adverse prognostic factor for pancreatic cancer, which may provide important information for prognostic assessment.

Cite

CITATION STYLE

APA

Zhan, H. X., Xu, J. W., Wang, L., Zhang, G. Y., & Hu, S. Y. (2015). Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer. World Journal of Surgical Oncology, 13(1). https://doi.org/10.1186/s12957-015-0510-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free